Equity Research Based on Stock Algorithm: Returns up to 46.45% in 1 Month

Equity Research

This forecast is part of the Stocks Under 10 Dollars Package, as one of I Know First’s forecast services. The full package includes daily stock predictions for a total of 20 stocks with bullish and bearish signals:

  • Top 10 stocks for the long position
  • Top 10 stocks for the short position

Package Name: Stocks Under 10 Dollars
Recommended Positions: Long
Forecast Length: 1 Month (06/18/2017 – 07/18/2017)
I Know First Average: 13.41%
Equity Research

I Know First’s State of the Art Algorithm accurately forecasted 7 out of 10 trades in this Stocks Under 10 Dollars Package for the 1 Month time period. The greatest return came from FOLD at 46.45%. NVAX and SGMO also performed well for this time horizon with returns of 31.82% and 24.16%, respectively. The package itself saw an overall return of 13.41%, providing investors with a 12.28% premium above the S&P 500’s return of 1.13% for the same time period.

Amicus Therapeutics, Inc., a biotechnology company, engages in the discovery, development, and commercialization of medicines for various rare and orphan diseases. Its principal product is the migalastat HCl, an orally administered small molecule pharmacological chaperone for the treatment of Fabry disease, which has completed two global Phase III registration studies.

Algorithmic traders utilize these daily forecasts by the I Know First market prediction system as a tool to enhance portfolio performance, verify their own analysis and act on market opportunities faster. This forecast was sent to current I Know First subscribers.

How to interpret this diagram

Please note-for trading decisions use the most recent forecast. Get today’s forecast and Top stock picks.